AZN vs EARN · P/E 28, $288.38B cap vs P/E 16, rev $15.5M
AstraZeneca PLC (AZN) versus Ellington Residential Mortgage (EARN) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Ellington Residential Mortgage (EARN) is a asset management company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported EARN revenue for 2025-03-31 was $15.5M. Net income was -$7.9M. Revenue was down 69.0% from 2024-12-31 to 2025-03-31. EARN currently screens at market cap $163.8M and trailing P/E 15.6.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. EARN currently screens at market cap $163.8M and trailing P/E 15.6.
Not investment advice. Open the AZN and EARN stock pages for the full models.
Not investment advice.